Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases

被引：6
|
作者：
Sengler, C. [1 ]
Niewerth, M. [1 ]
Kallinich, T. [2 ]
Nimtz-Talaska, A.
Haller, M.
Huppertz, H. -I. [3 ]
Minden, K. [1 ]
机构：
[1] German Rheumatism Res Ctr Berlin, Leibniz Inst, Epidemiol Unit, D-10117 Berlin, Germany
[2] Charite, Childrens Univ Hosp, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany
[3] Klinikum Bremen Mitte, Bremen, Germany
来源：
CLINICAL RHEUMATOLOGY | 2014年 / 33卷 / 01期
关键词：
Children; Disease activity; Flare; H1N1 influenza vaccination; Rheumatic disease; JUVENILE IDIOPATHIC ARTHRITIS; SAFETY; IMMUNOGENICITY;
D O I：
10.1007/s10067-013-2435-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The objective of this study is to evaluate complications and changes in health status (disease activity and flare) in response to the AS03-adjuvanted H1N1 vaccine in children with rheumatic diseases. We conducted a nationwide survey addressing paediatric rheumatology sites who participated in the national paediatric rheumatology database. Ninety patients were documented-38 % under treatment with biologicals-of whom 18 % suffered from complications (10 % local and 8 % systemic) with no relevant changes in median disease activity or flare rate during 4 weeks following the vaccination. The adjuvanted H1N1 influenza vaccine seems to be adequately tolerated in children with rheumatic diseases.
引用
收藏
页码：137 / 139
页数：3
相关论文
共 50 条
  • [1] Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases
    C. Sengler
    M. Niewerth
    T. Kallinich
    A. Nimtz-Talaska
    M. Haller
    H.-I. Huppertz
    K. Minden
    Clinical Rheumatology, 2014, 33 : 137 - 139
  • [2] Delayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine
    Javelle, Emilie
    Soulier, Benjamin
    Brosset, Christian
    Lorcy, Solene
    Simon, Fabrice
    VACCINE, 2011, 29 (06) : 1123 - 1125
  • [3] Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months
    Carmona, Alfonso
    Omenaca, Felix
    Tejedor, Juan C.
    Merino, Jose M.
    Vaman, Tejaswini
    Dieussaert, Ilse
    Gillard, Paul
    Aristegui, Javier
    VACCINE, 2010, 28 (36) : 5837 - 5844
  • [4] Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients
    Manuel, Oriol
    Pascual, Manuel
    Hoschler, Katja
    Giulieri, Stefano
    Alves, Deolinda
    Ellefsen, Kim
    Bart, Pierre-Alexandre
    Venetz, Jean-Pierre
    Calandra, Thierry
    Cavassini, Matthias
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (02) : 248 - 256
  • [5] Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine
    Walker, Woolf T.
    Faust, Saul N.
    EXPERT REVIEW OF VACCINES, 2010, 9 (12) : 1385 - 1398
  • [6] Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza
    Ortqvist, Ake
    Bennet, Rutger
    Rinder, Malin Ryd
    Lindblad, Hans
    Eriksson, Margareta
    VACCINE, 2012, 30 (39) : 5699 - 5702
  • [7] Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial
    Nolan, Terry
    Roy-Ghanta, Sumita
    Montellano, May
    Weckx, Lily
    Ulloa-Gutierrez, Rolando
    Lazcano-Ponce, Eduardo
    Kerdpanich, Angkool
    Palazzi Safadi, Marco Aurelio
    Cruz-Valdez, Aurelio
    Litao, Sandra
    Lim, Fong Seng
    Mascarenas de Los Santos, Abiel
    Rodriguez Weber, Miguel Angel
    Tinoco, Juan-Carlos
    Hernandez-de Mezerville, Marcela
    Faingezicht, Idis
    Kosuwon, Pensri
    Lopez, Pio
    Borja-Tabora, Charissa
    Li, Ping
    Durviaux, Serge
    Fries, Louis
    Dubin, Gary
    Breuer, Thomas
    Innis, Bruce L.
    Vaughn, David W.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (04): : 545 - 557
  • [8] A Prospective Study of the Factors Shaping Antibody Responses to the AS03-Adjuvanted Influenza A/H1N1 Vaccine in Cancer Outpatients
    Hottinger, Andreas F.
    George, Anne-Claude C.
    Bel, Michael
    Favet, Laurence
    Combescure, Christophe
    Meier, Sara
    Grillet, Stephane
    Posfay-Barbe, Klara
    Kaiser, Laurent
    Siegrist, Claire-Anne
    Dietrich, Pierre-Yves
    ONCOLOGIST, 2012, 17 (03): : 436 - 445
  • [9] Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents
    Garcia-Sicilia, J.
    Gillard, P.
    Carmona, A.
    Tejedor, J. C.
    Aristegui, J.
    Merino, J. M.
    Behre, U.
    Caplanusi, A.
    Vaman, T.
    Dieussaert, I.
    VACCINE, 2011, 29 (26) : 4353 - 4361
  • [10] HIV virological suppression influences response to the AS03-adjuvanted monovalent pandemic influenza A H1N1 vaccine in HIV-infected children
    Leahy, Timothy R.
    Goode, Michelle
    Lynam, Paul
    Gavin, Patrick J.
    Butler, Karina M.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2014, 8 (03) : 360 - 366
12345